Non-stimulant ADHD medications, such as atomoxetine and guanfacine, provide effective alternatives to stimulants, addressing ...

Guanfacine (sold under the brand name Intuniv) and Clonidine (sold under the brand name Kapvay) are both non-stimulant medications used to treat Attention Deficit Hyperactivity Disorder (ADHD), ...

Amphetamine- and methylphenidate-based drugs are the first-choice medications used for treating many people with attention deficit hyperactivity disorder (ADHD). They are available in a generic ...

Commonly marketed as an anti-aging product, nicotinamide riboside is an alternative form of vitamin B3 with few side effects. It may protect brain cells and lower the risk of heart disease. Every ...

We are now in the era of weight-loss drugs. Decisions on how these drugs will be used look likely to shape our future health and even what our society might look like. And, as researchers are ...

People with asthma are often treated with a combination of quick-relief and long-term controller medicines. Quick-Relief Medicine works quickly to relax your airways and help you breathe easier. You ...

Onyda XR contains an ER formulation of clonidine. It is FDA-approved to treat ADHD alone or in combination with a stimulant medication. Onyda XR can be used in people 6 years of age and older. It is a ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...

One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these ...

Since taking office on June 30, 2016, Philippine President Rodrigo Duterte has carried out a “war on drugs” that has led to the deaths of over 12,000 Filipinos to date, mostly urban poor.

MANILA – The Marcos administration's anti-drug campaign has so far netted a total of PHP49.82 billion worth of narcotics, the Philippine Drug Enforcement Agency (PDEA) reported on Sunday. From July ...

Oct 9 (Reuters) - The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be available for no more than $2 for a month's supply ...